Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians.


Updates from The Motley Fool

Latest updates on Navidea Biopharmaceuticals from Fool.com.
3 Stocks to Get on Your Watchlist

A once "golden" stock, a promising medical diagnostics company, and a sneaky play in the oil and ...

The 5 Most Misdiagnosed Diseases

Many of us implicitly trust our physicians to be right, but that isn't always the case. Here are ...

5 Stocks Under $10 Worth Buying

It's all about the Hamiltons, baby. These five stocks trade for single digits, but they long to b...

This Week in Biotech

A look back at the biggest stories this week in biotech and what they mean for investors.

The Stocks Wall Street Loves

Analysts are unanimously bullish, but do you agree with these Wall Street darlings?



Stock Performance

View Interactive NAVB Charts
Sponsored by

Key Data Points

Primary metrics and data points about Navidea Biopharmaceuticals.
Current Price: $0.45
Prev Close: $0.45
Open: $0.45
Bid: $0.45
Ask: $0.48
Day's Range: $0.45 - $0.47
52wk Range: $0.26 - $1.51
Volume: 442,383
Avg Vol 829,084
Market Cap: $70M
P/E (ttm): -3.18
EPS (ttm): ($0.14)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Navidea Biopharmaceuticals.
CAPS Rating 1 out of 5
 
81 Outperform
25 Underperform
CAPS All Stars
 
8 Outperform
11 Underperform

How do you think Navidea Biopharmaceuticals will perform against the market?



You pick for Navidea Biopharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Mark J. Pykett, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Navidea Biopharmaceuticals.

Neoprobe Corporation is a biomedical company which is engaged in the development and commercialization of innovative surgical and diagnostic products that enhance patient care by meeting the critical decision making needs of physicians.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Healthcare IT